McKesson Corporation · NYSE:MCK
McKesson — REMS Program Companies (RPC) — 2013 CE Provider Information Webinar
17 slides from McKesson's conference presentation, Jun 13, 2013
Slide 1: REMS Program Companies (RPC) 2013 CE Provider Information Webinar
REMS Program Companies (RPC) 2013 CE Provider Information Webinar June 13, 2013 -1- Copyright © 2013 Campbell Alliance, Ltd. All Rights Reserved. Copyright © 2013 Campbell Alliance, Ltd. All Rights Reserved. Confidential and Proprietary. Confidential and Proprietary.
Slide 2: Housekeeping
2013 Provider Information Webinar Housekeeping Before We Begin… Participants are asked to mute their lines when they are not speaking Questions submitted in advance of this webinar will be addressed during the latter part of today’s presentation The slides from today’s webinar will be posted o
Slide 3: Agenda
2013 Provider Information Webinar Agenda Provider Information Webinar Agenda Item Facilitator Time Introductions and Welcome Campbell Alliance 2:00pm-2:05pm REMS Compliant CE: 2013 RFA Introduction to the RPC and REMS CE CE Subteam 2:05pm-2:10pm REMS Target Audience Overview CE Subteam 2:10pm-2:20pm
Slide 4: Introductions – RPC Continuing Education Subteam
2013 Provider Information Webinar Introductions – RPC Continuing Education Subteam The Continuing Education (CE) Subteam is the group within RPC that is responsible for all CE-related aspects of the REMS. They are the primary authors of the 2013 CE RFA and will play a key role in the 2013 grant revi
Slide 5: Introduction to the RPC and REMS CE
2013 Provider Information Webinar Introduction to the RPC and REMS CE The REMS Program Companies are hosting this Webinar to provide information about the 2013 CE Grant RFA and grant request evaluation criteria to CE Providers. Background Information on the RPC and the ER/LA Opioid Analgesics REMS
Slide 6: REMS Target Audience Overview
2013 Provider Information Webinar REMS Target Audience Overview The FDA REMS defines the primary audience for REMS-compliant CE as those clinicians who are actively prescribing ER/LA opioid analgesics. Primary Audience for REMS-compliant CE The ER/LA Opioid REMS CE education/training goals have be
Slide 7: REMS Target Audience Overview
2013 Provider Information Webinar REMS Target Audience Overview Given the importance of the REMS to patient safety and public health, other health care professionals are also strongly encouraged to participate in REMS-compliant CE. While the primary audience for REMS CE defined by the FDA is ER/LA
Slide 8: REMS-compliant CE Requirements and Current Grantees
2013 Provider Information Webinar REMS-compliant CE Requirements and Current Grantees The RPC awarded five grants as a result of the 2012 RFA cycles. The Providers who received funding did an excellent job of ensuring REMS-compliance in their programs and detailing their activities, approach, and me
Slide 9: REMS-compliant CE Requirements and Current Grantees
2013 Provider Information Webinar REMS-compliant CE Requirements and Current Grantees REMS-compliant CE requirements are specifically defined by the FDA and all RPC-supported CE activities must adhere to all of these requirements. Requirements for REMS-Compliant CE “REMS-compliant CE” must: Incl
Slide 10: Overview of the 2013 CE RFA (Sections 1-5)
2013 Provider Information Webinar Overview of the 2013 CE RFA (Sections 1-5) The 2013 CE RFA has been updated from the 2012 document. The 2013 RFA places a strong emphasis on organization and demonstration of REMS-compliance while incorporating innovative learning elements. 1 Scope of Problem and
Slide 11: Grant Request Evaluation Criteria: Overview
2013 Provider Information Webinar Grant Request Evaluation Criteria: Overview The 2013 CE RFA has clearly defined evaluation criteria that outline ways in which Providers can demonstrate the strength of their proposals. While all RPC-supported CE must be REMS compliant and will be evaluated based on
Slide 12: Grant Request Evaluation Criteria: Timeline for Evaluation
2013 Provider Information Webinar Grant Request Evaluation Criteria: Timeline for Evaluation The submission date for all grant proposals in response to the 2013 CE RFA is Tue, July 16 at 5:00pm ET. The CE Subteam and the RPC will evaluate proposals and anticipate final decisions in late August, 2013
Slide 13: Review of Questions (Slide 1 of 4)
2013 Provider Information Webinar Review of Questions (Slide 1 of 4) The following questions were received for the Webinar. Question Response Could the learning format for this The RPC invites Providers to offer multi-modal learning opportunities activity be both online and live? I know which could
Slide 14: Review of Questions (Slide 2 of 4)
2013 Provider Information Webinar Review of Questions (Slide 2 of 4) The following questions were received for the Webinar. Question Response Can the CE Team While the primary focus of the 2013 RFA remains on educating individual prescribers of expound on what is ER/LA opioids, RPC understands that
Slide 15: Review of Questions (Slide 3 of 4)
2013 Provider Information Webinar Review of Questions (Slide 3 of 4) The following questions were received for the Webinar. Question Response What is the biggest The single greatest challenge is engaging ER/LA opioid prescribers to complete the full challenge RPC members activity and the assessment,
Slide 16: Review of Questions (Slide 4 of 4)
2013 Provider Information Webinar Review of Questions (Slide 4 of 4) The following questions were received for the Webinar. Question Response Is there a funding limit on individual There is no specified funding limit. RPC aims to award funding to a awards? portfolio of grants which are most likely t
Slide 17: Summary of Key RFA Information & Concluding Remarks
2013 Provider Information Webinar Summary of Key RFA Information & Concluding Remarks Grant Request Information The 2013 CE RFA is accessible on the RPC CE Website: http://ce.er-la-opioidrems.com/IwgCEUI/rems/ce.action The RPC Grant Management System will be accepting applications until 5:00pm E
REMS Program Companies (RPC) — 2013 CE Provider Information Webinar on 6ix